Stevanato Group S.p.A.

STVN XNYS

Market Cap

5.1B

Short interest (May 15)

0.4%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.46%

↓ 10.7%

Available Shares

700K

↓ 7.4%

Price Chart

Company Overview

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Company Info

Exchange: NYSE
CIK: 0001849853
Asset Type: CS

Market Data

Market Cap: $5,129,739,410
Employees: 5,795
Status: Active

Short Interest

Current Borrow Fee 0.46%
Range: 0.44% - 0.46%
Available Shares 700K
Range: 650K - 650K

Recent Changes

Fee Change: ↑ 0.8%
Available Change: ↓ 46.9%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime